Results 41 to 50 of about 62,886 (320)

Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators

open access: yesBMC Pharmacology and Toxicology, 2018
Background WHO pharmacovigilance indicators have been recommended as a useful tool towards improving pharmacovigilance activities. Nigeria with a myriad of medicines related issues is encouraging the growth of pharmacovigilance at peripheral centres ...
Abimbola O. Opadeyi   +2 more
doaj   +1 more source

Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems [PDF]

open access: yes, 2019
© 2019 Schifano, Chiappini, Corkery and Guirguis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
Chiappini, Stephania   +3 more
core   +4 more sources

The risk of preterm labor after COVID-19 vaccination before and during pregnancy

open access: yesFrontiers in Drug Safety and Regulation, 2023
Background: Pregnant women have a higher risk of severe illness and adverse pregnancy outcomes due to a SARS-CoV-2 infection. COVID-19 vaccination can prevent (severe) infection.
M. de Feijter   +5 more
doaj   +1 more source

Kounis Syndrome Associated With Selective Anaphylaxis to Cefazolin. [PDF]

open access: yes, 2018
info:eu-repo/semantics ...
Chambel, M   +5 more
core   +1 more source

Heparin pharmacovigilance in Brazil

open access: hybridRevista da Associação Médica Brasileira (English Edition), 2011
To investigate the biological origin of injectable unfractioned heparin available in Brazilian market by discussing the impact of the profile of commercial products and the changes in heparin monograph on the drug safety.The Anvisa data base for the Registered Products of Pharmaceutical Companies and the Dictionary of Pharmaceutical Specialties (DEF ...
Daniela Rezende Garcia Junqueira   +5 more
openalex   +4 more sources

Pharmacovigilance: An Overview [PDF]

open access: yesClinical Therapeutics, 2018
Pharmacovigilance (PV) is a relatively new discipline in the pharmaceutical industry. Having undergone rapid growth over the past 2 decades, PV now touches many other disciplines in the research and development enterprise. With its growth has come a heightened awareness and interest in the medical community about the roles that PV plays.
openaire   +3 more sources

Preparation for the Inspection of the Pharmacovigilance System

open access: yesБезопасность и риск фармакотерапии, 2021
The processes of planning, performing, documenting, and follow-up of pharmacovigilance system inspections are regulated by the Good Pharmacovigilance Practices (GVP) and local regulations.
B. K. Romanov
doaj   +1 more source

Multi-Task Pharmacovigilance Mining from Social Media Posts

open access: yes, 2018
Social media has grown to be a crucial information source for pharmacovigilance studies where an increasing number of people post adverse reactions to medical drugs that are previously unreported.
Chowdhury, Shaika   +2 more
core   +1 more source

Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences [PDF]

open access: yes, 2015
Herbal medicines are currently in high demand, and their popularity is steadily increasing. Because of their perceived effectiveness, fewer side effects and relatively low cost, they are being used for the management of numerous medical conditions ...
Horie, Toshiharu   +3 more
core   +1 more source

Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting

open access: yesMalaria Journal, 2020
Background Therapeutic ineffectiveness of artemisinin-based combination therapy (ACT) increases the risk of malaria-related morbidity and mortality, and raises healthcare costs.
Ronald Kiguba   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy